Meet the Team
Dr David Veitch
Dr Aaron Wernham
Dr Aaron Wernham is co-chief investigator for the HEALS2 study and a steering committee member for the UK Dermatology Clinical Trials Network (UKDCTN). He is a Consultant Dermatologist and Mohs Micrographic surgeon with a specialist interest in skin cancer and skin surgery.
He is currently appointed as co-lead for Skin Cancer for the Black Country and West Birmingham Integrated Care Board (ICB) and is an executive committee for the British Society for Dermatological Surgery (BSDS) and deputy chair for the West Midlands Skin Cancer Expert Advisory Group (EAG).
The Central Coordinating Team
Head of Trial Management
Clinical Trial Coordinator
Hello and thanks for visiting the HEALS2 trial page! We are based at the Clinical Trials Research Unit (CTRU) at the University of Leeds and work with the investigators and patients to implement and deliver the HEALS2 trial. We are responsible for the central management and monitoring of the trial, and we will analyse the data at the end of the trial.
On a day-to-day basis, this includes ensuring the trial is delivered in accordance with ethical and regulatory regulations, participants receive their trial intervention, and high quality data is recorded to answer the research questions. We monitor trial performance in accordance with key milestones, and try to ensure the trial is delivered to time and target, and on budget.
Through our research, we are passionate about improving the quality of patients’ lives. We are excited to be involved in the HEALS2 trial as it will allow patients to gain access to treatment which may not routinely be available, and therefore has the potential to shape clinical guidelines.
If you have any questions about the project, please contact HEALS2@leeds.ac.uk